IRCT201605169014N99已完成2 期
Effect of Teriparatide, Alendronate, Zoledronic Acid, and combined effect of Teriparatide and Alendronate treatment of primary osteoporosis: a randomized clinical trial
Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 44 years 至 99 years（—）
- 性别
- Female
入选标准
- •primary osteoporosis; T-score less than -2.5 in the lumbar spine or femoral neck; female; age of 44 to 99 years.
- •Exclusion criteria: secondary osteoporosis; using prednisolone more than 3 months; rheumatologic disease; malignancy; hypothyroidism; renal failure; history of surgery of parathyroid gland.
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Effect of Teriparatide, Alendronate, and Zoledronic Acid on treatment of secondary osteoporosisSecondary osteoporosis.Osteoporosis with pathological fractureIRCT201605159014N98Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences120
已完成
不适用
Preventive effects with teriparatide or alendronate on the progression of vertebral collapseOsteoporosisJPRN-UMIN000013014Kitakyushu Osteoporosis Trial Unit200
已完成
不适用
Comparison of alendronate and teriparatide for the bone mineral density around implant after total hip arthroplastycases after primary total hip arthroplastyJPRN-UMIN000016158Yokohama City University60
已完成
4 期
The Forteo Alendronate Comparator TrialOsteoporosisNCT02416271Eli Lilly and Company203
进行中（未招募）
不适用
Comparison of the Effects of Teriparatide with those of Risendronate on Lumbar Spine Volumetric Bone Mineral Density in GLucocorticpid-Induced Osteoporosis in Men - GHDHEUCTR2006-006315-68-DEEli Lilly and Company Limited104